TCT-12 Results From the CAMI1 Study: Selective CRP Apheresis as a New Treatment Option in Acute Myocardial Infarction

Journal of the American College of Cardiology(2019)

引用 0|浏览15
暂无评分
摘要
Inflammation is increasingly recognized as an important pathogenic feature in cardiovascular disease. In patients with ST-segment elevation myocardial infarction (STEMI), C-reactive protein (CRP), the prototype human acute phase protein, is a marker of poor prognosis and independently predicts 30-
更多
查看译文
关键词
selective crp apheresis,myocardial infarction,acute myocardial infarction,cami1 study
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要